complete protease inhibitor cocktail (Boehringer Mannheim GmbH, Indianapolis, IN, USA). Protein was quantiﬁed by Bio-Rad protein assay kit (Bio-Rad, Hercules, CA, USA), with bovine serum albumin as control. Protein (100 mg) was separated by 8% sodium dodecyl sulfate polyacrylamide gel electrophoresis. Membrane was detected by BDKRB2, IRX1 and PAK1 antibodies. GAPDH antibody was used for internal control (Supplementary Table). Statistics Data are shown as mean±s.d. The statistical difference between the two groups was examined by Student’s t-test. Multiple comparisons were performed by one-way analysis of variance. Po0.05 was considered statistically signiﬁcant. References Alarcon P, Rodriguez-Seguel E, Fernandez-Gonzalez A, Rubio R, Gomez-Skarmeta JL. (2008). A dual requirement for Iroquois genes during Xenopus kidney development. Development 135: 3197–3207. Altundag K, Elkiran ET, Altundag O. (2004). Vascular endothelial growth factor is associated with the efﬁcacy of endocrine therapy in patients with advanced breast carcinoma. Cancer 100: 1768–1769; author reply 1769. Andoh T, Akira A, Saiki I, Kuraishi Y. (2010). Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells. Peptides 31: 238–241. Basu GD, Liang WS, Stephan DA, Wegener LT, Conley CR, Pockaj BA et al. (2006). A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res 8: R69. Becker MB, Zulch A, Bosse A, Gruss P. (2001). Irx1 and Irx2 expression in early lung development. Mech Dev 106: 155–158. Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G et al. (2008). Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 68: 4494–4499. Bennett KL, Romigh T, Eng C. (2009). Disruption of transforming growth factor-beta signaling by ﬁve frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis. Cancer Res 69: 9301–9305. Bessard A, Fremin C, Ezan F, Fautrel A, Gailhouste L, Baffet G. (2008). RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo. Oncogene 27: 5315–5325. Cai XZ, Wang J, Li XD, Wang GL, Liu FN, Cheng MS et al. (2009). Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther 8: 1360–1368. Calderon AJ, Lavergne JA. (2005). RNA interference: a novel and physiologic mechanism of gene silencing with great therapeutic potential. PR Health Sci J 24: 27–33. Deryugina EI, Quigley JP. (2008a). Chapter 2 Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inﬂammatory and tumor cells or puriﬁed effector molecules. Methods Enzymol 444: 21–41. Deryugina EI, Quigley JP. (2008b). Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis. Histochem Cell Biol 130: 1119–1130. Fryer BH, Field J. (2005). Rho, Rac, Pak and angiogenesis: old roles and newly identiﬁed responsibilities in endothelial cells. Cancer Lett 229: 13–23. Fujimoto A, Onodera H, Mori A, Nagayama S, Yonenaga Y, Tachibana T. (2006). Tumour plasticity and extravascular circula- tion in ECV304 human bladder carcinoma cells. Anticancer Res 26: 59–69. Galan Moya EM, Le Guelte A, Gavard J. (2009). PAKing up to the endothelium. Cell Signal 21: 1727–1737. IRX1 inﬂuences peritoneal spreading and metastasis J Jiang et al Conﬂict of interest The authors declare no conﬂict of interest. Acknowledgements This work was supported, in part, by grants from the National Natural Science Foundation of China (30572127, 30770961 and 30973486), the Chinese National High Tech Program (863-2006AA02A402 and 2006AA02A301), Key Research Project from Shanghai Science and Technology Commission (09DZ1950101 and 09JC1409600) and Shanghai Charity Foundation for Cancer Research. Gartel AL, Kandel ES. (2006). RNA interference in cancer. Biomol Eng 23: 17–34. Getmanova EV, Chen Y, Bloom L, Gokemeijer J, Shamah S, Warikoo V et al. (2006). Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem Biol 13: 549–556. Gu W, Putral L, McMillan N. (2008). siRNA and shRNA as anticancer agents in a cervical cancer model. Methods Mol Biol 442: 159–172. Guo X, Liu W, Pan Y, Ni P, Ji J, Guo L et al. (2010). Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene 29: 3908–3920. Gupta GP, Massague J. (2006). Cancer metastasis: building a framework. Cell 127: 679–695. Hao X, Sun B, Zhang S, Zhao X. (2002). Microarray study of vasculogenic mimicry in bi-directional differentiation malignant tumor. Zhonghua Yi Xue Za Zhi 82: 1298–1302. Ikeda Y, Hayashi I, Kamoshita E, Yamazaki A, Endo H, Ishihara K et al. (2004). Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Res 64: 5178–5185. Ishihara K, Kamata M, Hayashi I, Yamashina S, Majima M. (2002). Roles of bradykinin in vascular permeability and angiogenesis in solid tumor. Int Immunopharmacol 2: 499–509. Kramarenko II, Bunni MA, Raymond JR, Garnovskaya MN. (2010). Bradykinin B2 receptor interacts with integrin alpha5beta1 to transactivate epidermal growth factor receptor in kidney cells. Mol Pharmacol 78: 126–134. Krankel N, Katare RG, Siragusa M, Barcelos LS, Campagnolo P, Mangialardi G et al. (2008). Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovasculariza- tion potential. Circ Res 103: 1335–1343. Kumar R, Vadlamudi RK. (2002). Emerging functions of p21- activated kinases in human cancer cells. J Cell Physiol 193: 133–144. Li X, Liu F, Li F. (2010). PAK as a therapeutic target in gastric cancer. Expert Opin Ther Targets 14: 419–433. Liu F, Li X, Wang C, Cai X, Du Z, Xu H et al. (2009). Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1. Int J Cancer 125: 2511–2519. Lorch JH, Thomas TO, Schmoll HJ. (2007). Bortezomib inhibits cell- cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancer. Cancer Res 67: 727–734. Lu Y, Yu Y, Zhu Z, Xu H, Ji J, Bu L et al. (2005). Identiﬁcation of a new target region by loss of heterozygosity at 5p15.33 in sporadic gastric carcinomas: genotype and phenotype related. Cancer Lett 224: 329–337. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe’er J et al. (1999). Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739–752. 4507 Oncogene